Calvin B. Harley,Laurence Elias,Jennifer Smith,Mark J. Ratain,Fabio Benedetti
申请号：
US14505366
公开号：
US09617583B2
申请日:
2014.10.02
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention provides methods for determining the susceptibility of cancer patients to developing adverse reactions if treated with a telomerase inhibitor drug by measurement of telomere length in appropriate cells of the patient prior to initiation of the telomerase inhibitor treatment.
